Estimate delivery
Actual EPS versus consensus
Actual and estimated EPS are displayed in reported currency on the same quarterly basis.
US Equity · NASDAQ · Earnings Dossier
PMCB earnings intelligence
PharmaCyte Biotech IncHealthcare · Biotechnology · USD reporting basis
Current earnings profile
Mixed earnings transmission
Delivery and market response do not currently form a persistent directional pattern.
Evidence85/100 · Deep
Next scheduled catalyst
Friday 14 August 2026
Time unconfirmed · Fiscal period ending 30 Apr 2026
82event risk
High
Countdown1 dayscalendar proximity
EPS estimate-provider consensus
Estimate growth-versus comparable year-ago actual
Historical movement6.6%average absolute next weekly close
Three-year earnings transmission
Delivered earnings power versus market price
Three-year relationship unavailable
Earnings power must be positive at the start of the three-year window.
Beat rate0.0%0 beats in 3 measured quarters
Average surprise-173.0%median -222.0%
Delivery streak11 consecutive in-line reports
Average response+0.5%12 measured reactions
Result-price confirmation50%same directional sign
Surprise variability126.1 ptspopulation dispersion
Price acceptance
Surprise and next weekly close
The response uses the first completed weekly close after the public report against the prior completed weekly close.
Fundamental delivery
Quarterly revenue and net income
Reported financial statements provide scale and earnings quality context around the headline EPS result.
Transmission matrix
Does price confirm delivery?
Upper right and lower left observations confirm the sign of delivery. The other quadrants expose expectation or resilience effects.
Current business context
Growth, quality and valuation
EPS growth-year on year
Revenue growth-year on year
Average surprise-111.0%latest four quarters
SUE-0.71standardised surprise
Net margin-trailing basis
Cash conversion0.27xcash flow / net income
P/E-current snapshot
Data completeness43%alphavantage
Market context
Positioning into the event
Weekly close0.59 USDcompleted week
13-week return-21.9%price momentum
Fair-value gap-60.0%price versus current fair value
Relative strength-36.5exchange benchmark
Trend signalInactiveweekly architecture
Next-week stateNegative41.6%
Market context describes the setup surrounding the report. It does not convert the earnings event into a directional forecast.
Reported evidence ledger
Quarter-by-quarter delivery and acceptance
Each row preserves the reported estimate, public date, statement context and conservative weekly reaction measurement.
Reported / periodEPS actual / estimateSurpriseEPS growthRevenue / growthNext close / four weeksRead
Reported / period1 Jul 202630 Apr 2026 · exact
EPS actual / estimate-0.01 / -USD
Surprise-Unavailable
EPS growth-100.6%year on year
Revenue / growth0- · USD
Next close / four weeks-7.1% / -22.0%completed weekly closes
ReadUnavailableresult versus price sign
Reported / period17 Mar 202631 Jan 2026 · exact
EPS actual / estimate-0.17 / 0.00USD
Surprise-Unavailable
EPS growth+61.6%year on year
Revenue / growth0- · USD
Next close / four weeks-0.5% / -5.4%completed weekly closes
ReadUnavailableresult versus price sign
Reported / period18 Dec 202531 Oct 2025 · exact
EPS actual / estimate-1.24 / 0.00USD
Surprise-Unavailable
EPS growth-220.1%year on year
Revenue / growth0- · USD
Next close / four weeks-15.9% / -13.6%completed weekly closes
ReadUnavailableresult versus price sign
Reported / period11 Aug 202531 Jul 2025 · exact
EPS actual / estimate-1.23 / 0.00USD
Surprise-Unavailable
EPS growth-164.7%year on year
Revenue / growth0- · USD
Next close / four weeks+8.4% / +13.4%completed weekly closes
ReadUnavailableresult versus price sign
Reported / period2 Jul 202530 Apr 2025 · exact
EPS actual / estimate1.58 / 0.00USD
Surprise-Unavailable
EPS growth+599.8%year on year
Revenue / growth0- · USD
Next close / four weeks+7.8% / -7.3%completed weekly closes
ReadUnavailableresult versus price sign
Reported / period17 Mar 202531 Jan 2025 · exact
EPS actual / estimate-0.44 / -USD
Surprise-Unavailable
EPS growth-525.0%year on year
Revenue / growth0- · USD
Next close / four weeks0.0% / -22.2%completed weekly closes
ReadUnavailableresult versus price sign
Reported / period13 Dec 202431 Oct 2024 · exact
EPS actual / estimate-0.39 / -USD
Surprise-Unavailable
EPS growth-50.4%year on year
Revenue / growth0- · USD
Next close / four weeks0.0% / 0.0%completed weekly closes
ReadUnavailableresult versus price sign
Reported / period13 Aug 202431 Jul 2024 · exact
EPS actual / estimate1.90 / -USD
Surprise-Unavailable
EPS growth+784.0%year on year
Revenue / growth0- · USD
Next close / four weeks-0.3% / -15.6%completed weekly closes
ReadUnavailableresult versus price sign
Reported / period29 Jul 202430 Apr 2024 · exact
EPS actual / estimate-0.32 / -USD
Surprise-Unavailable
EPS growth-year on year
Revenue / growth0- · USD
Next close / four weeks-5.6% / -16.2%completed weekly closes
ReadUnavailableresult versus price sign
Reported / period18 Mar 202431 Jan 2024 · exact
EPS actual / estimate-0.07 / -0.07USD
Surprise0.0%In-Line
EPS growth-year on year
Revenue / growth0- · USD
Next close / four weeks+25.1% / +14.4%completed weekly closes
ReadContainedresult versus price sign
Reported / period15 Dec 202331 Oct 2023 · exact
EPS actual / estimate-0.26 / -0.08USD
Surprise-222.0%Miss
EPS growth-year on year
Revenue / growth0- · USD
Next close / four weeks+1.8% / -2.3%completed weekly closes
ReadDivergedresult versus price sign
Reported / period18 Sep 202331 Jul 2023 · exact
EPS actual / estimate-0.28 / -0.07USD
Surprise-297.1%Miss
EPS growth-year on year
Revenue / growth0- · USD
Next close / four weeks-7.2% / -16.4%completed weekly closes
ReadConfirmedresult versus price sign
Reproducible method
How the earnings dossier is measured
Reported diluted EPS is compared with the stored estimate for the same fiscal period. Moves within ±0.5% are classified as in-line.
The first completed weekly close after the public date is compared with the prior completed weekly close. Four-week response uses the first close at least 21 days later.
Risk combines proximity, average absolute price movement, surprise variability, estimate availability and timing certainty. It does not score direction.
Exact public dates are used when stored. Missing estimates, timing and statement fields remain missing. No result or reaction is filled from a future observation.
Independent market research for education. Not investment advice, a recommendation, forecast, target or execution instruction.